🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this trial is to conduct a randomized, multicenter, placebo-cont...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-08
Trial ID
NCT06580288
Treatments Being Tested
A study Comparing the Clinical Benefit of Finerenone Versus a Fixed-Dose Co...
Status
Recruiting
Location
Sarfez Pharmaceuticals, Inc.
Start Date
2025-12-01
Trial ID
NCT07223502
Using spironolactone as the control, to assess the efficacy and safety of f...
Status
Recruiting
Location
the first affiliated hospital of Chongqing medical university
Start Date
2024-06-04
Trial ID
NCT06457074
Treatments Being Tested
Elevated aldosterone causes moderate to severe increase in blood pressure, ...
Status
Enrolling By Invitation
Location
Hypertension Center of People's Hospital of Xinjiang Uygur Autonomous Region
Start Date
2023-04-16
Trial ID
NCT05688579
Treatments Being Tested
Researchers are looking for a better way to treat people who have non-diabe...
Status
Completed
Location
Nephrology Consultants, LLC
Start Date
2021-09-21
Trial ID
NCT05047263
Treatments Being Tested
Finerenone is a new selective nonsteroidal mineral corticoid receptor antag...
Status
Unknown
Location
Multiple Locations
Start Date
2023-08-01
Trial ID
NCT05974566
This study will investigate the utility of a polypill-based strategy for pa...
Status
Recruiting
Location
UT Southwestern Medical Center
Start Date
2024-03-11
Trial ID
NCT06143566
Treatments Being Tested
Finerenone is developed for the treatment of diabetic kidney disease (adult...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-16
Trial ID
NCT02956109
This study is testing whether finerenone, when compared to placebo, is a to...
Status
Not Yet Recruiting
Location
Centre Hospitalier de l'Université de Montréal
Start Date
2027-01
Trial ID
NCT07775482
Treatments Being Tested
This study should estimate the dose proportionality of BAY94-8862 IR tablet...
Status
Completed
Location
CRS Clinical-Research-Services Mönchengladbach GmbH
Start Date
2012-09-17
Trial ID
NCT01687920
Treatments Being Tested